Sector dividends Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Berne S.E.
2026-09-18
|
5-day change | 1st Jan Change | ||
| 229.13 CHF | -1.98% |
|
+0.52% | - |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.02% | 1.17% | 31.88x | 4.26x | 5.74x | 17.19x | 24.05x | 46.28B | ||
| -.--% | -.--% | 34.31x | 6.27x | 3.31x | 14.29x | 21.6x | 43.85B | ||
| -.--% | -.--% | -19.53x | 20.19x | 224.63x | -20.86x | -19.68x | 40.93B | ||
| -.--% | -.--% | 45.96x | 7.78x | 5.31x | 29.05x | 33.43x | 39.9B | ||
| 0.42% | 0.44% | 27.18x | 2.21x | 7.83x | 19.98x | 23.53x | 29.5B | ||
| -.--% | -.--% | 34.82x | 24.98x | 5.71x | 25.95x | 27.15x | 17.09B | ||
| 1.05% | 1.19% | 25.48x | 2.83x | 2.19x | 9.51x | 14.74x | 15.22B | ||
| -.--% | -.--% | -55.89x | 28.01x | 9.19x | 224.28x | -2034.7x | 14.05B | ||
| -.--% | -.--% | 74.38x | 4.41x | 3.93x | 15.26x | 18.74x | 13.27B | ||
| -.--% | -.--% | 27.86x | 1.32x | 1.84x | 11.31x | 12.89x | 12.66B | ||
| 0.44% | 0.44% | 52.38x | 4.57x | 8.69x | 24.67x | 29.43x | 11.35B | ||
| 0.56% | 0.7% | 39.36x | 4.58x | 4.68x | 19.99x | 31.74x | 10.89B | ||
| -.--% | -.--% | -419.24x | 2.74x | 12.86x | 76.39x | 99.94x | 11.43B | ||
| -.--% | -.--% | -30.41x | 8.84x | 80.62x | -20.33x | -19.71x | 9.79B | ||
| -.--% | -.--% | -25.66x | 7.55x | 97.38x | -25.62x | -42.38x | 9.1B | ||
| -.--% | -.--% | 30.75x | - | 16.07x | 29.33x | 28.65x | 9.25B | ||
| 0.31% | 0.42% | 22.49x | 2.38x | 4.5x | 12.1x | 15.42x | 8.96B | ||
| -.--% | -.--% | -21.52x | 7.43x | 8892.1x | -17.56x | -17.3x | 8.35B | ||
| Average | 0.21% | 0.24% | -6.97x | 8.26x | 521.48x | 24.72x | -97.36x | 19.55B | |
| Weighted average by Cap. | 0.25% | 0.29% | 6.70x | 8.71x | 246.57x | 21.52x | -64.49x |
Select your edition
All financial news and data tailored to specific country editions
















